AU510864B2 - Halopregnadienes - Google Patents

Halopregnadienes

Info

Publication number
AU510864B2
AU510864B2 AU20471/76A AU2047176A AU510864B2 AU 510864 B2 AU510864 B2 AU 510864B2 AU 20471/76 A AU20471/76 A AU 20471/76A AU 2047176 A AU2047176 A AU 2047176A AU 510864 B2 AU510864 B2 AU 510864B2
Authority
AU
Australia
Prior art keywords
halopregnadienes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU20471/76A
Other languages
English (en)
Other versions
AU2047176A (en
Inventor
G. and Meister C Avner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of AU2047176A publication Critical patent/AU2047176A/en
Application granted granted Critical
Publication of AU510864B2 publication Critical patent/AU510864B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
AU20471/76A 1975-12-12 1976-12-10 Halopregnadienes Expired AU510864B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1615075A CH626632A5 (en) 1975-12-12 1975-12-12 Process for the preparation of halopregnadienes
CHCH16150/75 1975-12-12

Publications (2)

Publication Number Publication Date
AU2047176A AU2047176A (en) 1978-06-15
AU510864B2 true AU510864B2 (en) 1980-07-17

Family

ID=4414834

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20471/76A Expired AU510864B2 (en) 1975-12-12 1976-12-10 Halopregnadienes

Country Status (19)

Country Link
JP (1) JPS5273852A (ja)
AT (1) AT353432B (ja)
AU (1) AU510864B2 (ja)
BE (1) BE849267A (ja)
CA (1) CA1078824A (ja)
CH (2) CH626632A5 (ja)
DD (1) DD128682A5 (ja)
DE (1) DE2655802A1 (ja)
DK (1) DK142326B (ja)
ES (2) ES454119A1 (ja)
FR (1) FR2358152A1 (ja)
GB (1) GB1563595A (ja)
HU (1) HU176936B (ja)
IE (1) IE44512B1 (ja)
IL (1) IL51085A (ja)
NL (1) NL7613711A (ja)
NZ (1) NZ182865A (ja)
SE (1) SE7613919L (ja)
ZA (1) ZA767381B (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT78973A (en) * 1984-07-25 1984-08-01 Joao Emerico Villax New preparation process of the 9alpha-fluoro 17,21-acylates or hidroxilades in 17 and 21 chloro-corticosteroid

Also Published As

Publication number Publication date
DK557576A (ja) 1977-06-13
GB1563595A (en) 1980-03-26
SE7613919L (sv) 1977-06-13
ZA767381B (en) 1977-11-30
FR2358152B1 (ja) 1982-10-22
AT353432B (de) 1979-11-12
NL7613711A (nl) 1977-06-14
DK142326B (da) 1980-10-13
JPS5273852A (en) 1977-06-21
IL51085A0 (en) 1977-02-28
DK142326C (ja) 1981-03-09
AU2047176A (en) 1978-06-15
CA1078824A (en) 1980-06-03
CH626632A5 (en) 1981-11-30
HU176936B (hu) 1981-06-28
IE44512L (en) 1977-06-12
ES465551A1 (es) 1978-09-16
CH626094A5 (en) 1981-10-30
NZ182865A (en) 1979-06-08
FR2358152A1 (fr) 1978-02-10
IL51085A (en) 1980-09-16
BE849267A (fr) 1977-06-10
ES454119A1 (es) 1978-03-01
IE44512B1 (en) 1981-12-30
ATA914176A (de) 1979-04-15
DD128682A5 (de) 1977-12-07
DE2655802A1 (de) 1977-06-16

Similar Documents

Publication Publication Date Title
AU1108376A (en) Polyhemoglobin
AU1025376A (en) Pourer-stopper
AU1670276A (en) Tetrahydro-isoquinolines
AU1230276A (en) Amidinoureas
AU1230176A (en) Imidinoureas
AU2018176A (en) Pyrazinecarboxamides
AU1441776A (en) Thieno-pyridines
AU1373876A (en) Bottlecap
AU1829576A (en) Hydropyrimidines
AU1667476A (en) Chroman-4-ones
AU1128976A (en) Magneto-alternator
AU1417076A (en) Propargyl-2 phenylamino-2-impazolines
AU1637076A (en) Banjo-shaped axle-casing
AU1710076A (en) Dihydrooxadiazinones
AU1867676A (en) N-acetylmuramyl-dorl-alanyl-dorl-isoglutamine
AU1722876A (en) Antimacassar
AU1565576A (en) L- pyroglutamyl-l-prolinamide
AU1719976A (en) Silacyclo pentenyl-bis-epsilon-caprolactam
AU1408076A (en) Lysolipin Antibioties
AU1520376A (en) Benzocycloheptathiophens
AU1191776A (en) Fluoro-prostaglandins
AU1393076A (en) Dihydromocimycin
AU1804876A (en) 4-hydroxymethyl-2-pyrrolidinones
AU1398876A (en) Aryl-di-thioureas
AU1625476A (en) Aryltetralins